Article

Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to…

medRxiv · 2024 · Su, C.; Kent, C. L.; Pierpoint, M.; Floyd, W.; Luo, L.; Williams, N. T.; Ma, Y.; Peng, B.; Lazarides, A. L.; Subramanian, A.; Himes, J. E.; Perez, V. M.; Hernansaiz-Ballesteros, R. D.; Roche, K. E.; Modliszewski, J. L.; Selitsky, S. R.; Shinohara, M.; Wisdom, A. J.; Moding, E. J.; Mowery, Y. M.; Kirsch, D. G.

Key facts

Title Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to stimulate CD8 T cells in an autochthonous mouse model of sarcoma
First author Su, C.; Kent, C. L.; Pierpoint, M.; Floyd, W.; Luo, L.; Williams, N. T.; Ma, Y.; Peng, B.; Lazarides, A. L.; Subramanian, A.; Himes, J. E.; Perez, V. M.; Hernansaiz-Ballesteros, R. D.; Roche, K. E.; Modliszewski, J. L.; Selitsky, S. R.; Shinohara, M.; Wisdom, A. J.; Moding, E. J.; Mowery, Y. M.; Kirsch, D. G.
Journal medRxiv
Published Jan 1, 2024
DOI 10.1101/2024.01.03.573968
Product codes mentioned JJH, MVU, PFF, PFT

At a glance

  • None FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature